Passing of Nanocarriers across the Histohematic Barriers: Current Approaches for Tumor Theranostics

Over the past several decades, nanocarriers have demonstrated diagnostic and therapeutic (i.e., theranostic) potencies in translational oncology, and some agents have been further translated into clinical trials. However, the practical application of nanoparticle-based medicine in living organisms i...

Descripción completa

Detalles Bibliográficos
Autores principales: Gareev, Kamil, Tagaeva, Ruslana, Bobkov, Danila, Yudintceva, Natalia, Goncharova, Daria, Combs, Stephanie E., Ten, Artem, Samochernych, Konstantin, Shevtsov, Maxim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096980/
https://www.ncbi.nlm.nih.gov/pubmed/37049234
http://dx.doi.org/10.3390/nano13071140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10096980/
https://www.ncbi.nlm.nih.gov/pubmed/37049234
http://dx.doi.org/10.3390/nano13071140

Ejemplares similares